Communities break fundraising record during The Longest Day
By
Foster Stubbs
Jul 24, 2024
63 Charter Senior Living communities across the nation raised money for Alzheimer’s research as part of the Alzheimer’s Association’s The Longest Day initiative. Find out more, and learn how to submit...
Risk of Parkinson’s disease heightened in people with anxiety
Jul 22, 2024
Certain clinical features may identify those who may be in the prodromal phase of Parkinson’s disease.
Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
Increasing RN staffing hours reduces injury-related ED visits by assisted living residents with dementia:...
By
Kimberly Bonvissuto
Jul 19, 2024
A new study found that increasing staffing hours of registered nurses in assisted living communities led to a 53% decrease in injury-related emergency department visits by residents living with Alzheimer’s...
Benzodiazepines not tied to higher dementia risk in older adults
Jul 16, 2024
Potential class-dependent associations may exist, however.
State budget has ‘positive steps’ but does not do enough for providers, residents, groups say
By
Lois A. Bowers
Jul 22, 2024
Senior living industry advocates in Pennsylvania say they are encouraged by steps to support older adults evident in the recently passed state budget, but they say much more needs to be done to support...
Infrastructure, data analytics popular tech investments among long-term care providers
By
Lois A. Bowers
Jul 26, 2024
Infrastructure for internet connectivity was the most common technology investment made over the past year by long-term care operators responding to a new survey, and data analytics tools were the most...
FDA clears nasal spray for moderate Alzheimer’s disease in first patient
By
Donna Shryer
Jul 16, 2024
Two recent developments in Alzheimer’s disease research offer new hope for patients and their families. Among these, in June, Tiziana Life Sciences received Food and Drug Administration clearance...
Nightmares in midlife may point to future cognitive decline, dementia
Jul 12, 2024
The findings were seen in middle-aged and older adults from the general population who did not have Parkinson’s disease.
Models constructed to predict decline over time in MCI, mild dementia
Jul 10, 2024
For a hypothetical patient with MCI, a baseline MMSE of 28 and CSF Aβ1-42 of 925 pg/mL, an MMSE of 20 was predicted after 6.0 years and after 8.6 years with a hypothetical treatment.